Quarterly report pursuant to Section 13 or 15(d)

Segment Disclosures - Operating Segments (Details)

v3.22.2.2
Segment Disclosures - Operating Segments (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
USD ($)
Sep. 30, 2021
USD ($)
Sep. 30, 2022
USD ($)
segment
Sep. 30, 2021
USD ($)
Segment Reporting [Abstract]        
Number of reportable segments | segment     2  
Segment Reporting Information [Line Items]        
Revenue $ 3,329 $ 3,049 $ 9,361 $ 7,170
Cost of revenue 1,643 1,242 4,825 2,836
Gross profit 1,686 1,807 $ 4,536 4,334
Number of reportable segments | segment     2  
EksoHealth        
Segment Reporting Information [Line Items]        
Revenue 3,224 2,716 $ 8,333 6,306
Cost of revenue 1,524 1,044 4,170 2,326
Gross profit 1,700 1,672 4,163 3,980
EksoWorks        
Segment Reporting Information [Line Items]        
Revenue 105 333 1,028 864
Cost of revenue 119 198 655 510
Gross profit $ (14) $ 135 $ 373 $ 354